Barclays
MDXG icon

Barclays’s MiMedx Group MDXG Stock Holding History

Barclays’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-194,300
Closed -$1.2M – 7161
2018
Q3 		$1.2M Sell
194,300
-237,400
-55% -$1.07M ﹤0.01% 3459
2018
Q2 		$2.76M Buy
431,700
+162,300
+60% +$1.16M ﹤0.01% 2269
2018
Q1 		$1.88M Buy
269,400
+240,200
+823% +$2.8M ﹤0.01% 2522
2017
Q4 		$368K Buy
29,200
+10,400
+55% +$127K ﹤0.01% 4145
2017
Q3 		$223K Buy
+18,800
New +$279K ﹤0.01% 4333

Other funds holding MDXG

Essex Woodlands Management
Essex Woodlands Management The Woodlands, Texas $323M AUM 25.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
OP Asset Management
OP Asset Management Helsinki $11.8B AUM 34.59% 1-Year Est. Return
Isthmus Partners
Isthmus Partners Madison, Wisconsin $1.04B AUM 19.97% 1-Year Est. Return
Apricus Wealth
Apricus Wealth Beaufort, South Carolina $222M AUM 24.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays's MDXG Position: Q3 2026 in Review

Barclays increased its MiMedx Group (MDXG) stake by 36% in Q3 2026, buying an estimated $209K and bringing the position to 180,950 shares worth $843K. The position accounts for ﹤0.01% of the portfolio, ranked #3168.

Barclays first reported a position in MDXG in Q2 2013 and has held it in 38 quarters since. The position peaked at $9.38M in Q3 2017. 112 funds tracked by Wall St. Rank hold MDXG as of Q3 2026.

  • Barclays held 180,950 shares of MiMedx Group worth $843K as of Q3 2026.
  • Barclays bought 47,680 MiMedx Group shares in Q3 2026, an estimated $209K.
  • MiMedx Group made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3168 holding.
  • Barclays first reported a position in MiMedx Group in Q2 2013 and has held it in 38 quarters since.
  • Barclays's MiMedx Group position peaked at $9.38M in Q3 2017.
  • 112 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.